• Michon P, Plennevaux N
  • PV 256
  • Juin 2005
  • : Chien, chat

1 - Acosta AD, Gomar C, Correa-Natalini C et coll. Analgesic effects of epidurally administered levogyral ketamine alone or incombination with morphine on intraoperative and postoperative pain in dogs undergoing ovariohysterectomy. Am. J. Vet. Res. 2005;66(1):54-61.
2 - Adler RH. Psychotropic agents in the management of chronic pain. J. Human Stress. 1978;4(2):13-17.
3 - Allen RM, Dykstra LA. Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist. Psychopharmacology (Berl). 2000;148(1):59-65.
4 - Allen RM, Dykstra LA. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats. Psychopharmacology (Berl). 1999;142(2):209-214.
5 - Amital H, Applbaum YH, Vasiliev L et coll. Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate. Clin. Rheumatol. 2004;23(4):330-332.
6 - Angst MS, Koppert W, Pahl I et coll. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003;106(1-2):49-57.
7 - Besson JM, Chaouch A, Chitour D. Voies, relais et centres d'intégration des messages nociceptifs. Recueil de Médecine Vétérinaire. 1986;162(12):1277-1296.
8 - Brugère H, Le Bars D. Terminologie de la douleur. Recueil de Médecine Vétérinaire. 1986;162(12):1275-1276.
9 - Bryson HM, Wilde MI. Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states. Drugs Aging. 1996;8(6):459-476.
10 - Cadoré JL. Comment reconnaître la douleur. Point Vét. 1993;24(149):17-26.
11 - Cameron LB. Neuropsychotropic drugs as adjuncts in the treatment of cancer pain. Oncology (Huntingt). 1992;6(10):65-72;discussion 72:77-80.
12 - Carlton SM, Rees H, Tsuruoka M et coll. Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys. Eur. J. Pain. 1998;2(3):229-238.
13 - Carlton SM, Hargett GL. Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats. Neurosci. Lett. 1995;198(2):115-118.
14 - Carrol EN, Fine E, Ruff RL et coll. A four-drug pain regimen for head and neck cancers. Laryngoscope. 1994;104(6 Pt 1):694-700.
15 - Cesselin F. Les endomorphines. Recueil de Médecine Vétérinaire. 1986;162(12):1311-1319.
16 - Cleary JF. Cancer pain management. Cancer Control. 2000;7(2):132-141.
17 - Clifford DB. Treatment of pain with antidepressants. Am. Fam. Physician. 1985;31(2):181-185.
18 - Christensen D, Guilbaud G, Kayser V. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats. Anesthesiology. 2000;92(3):786-794.
19 - Cogny M, Pouliquen H. Emploi de la morphine chez le cheval. Point Vét. 252:77.
20 - Deneuche AJ, Dufayet C, Goby L et coll. Analgesic comparison of meloxicam or ketoprofen for orthopedic surgery in dogs. Vet. Surg. 2004;33(6):650-660.
21 - Deschamps JY. Vade-mecum de gestion de la douleur chez le chien et le chat. Med'Com Ed. 2001:154p.
22 - Dohoo S, Tasker RAR, Donald A. Pharmacokinetics of parenteral and oral sustained-release morphine. J. Vet. Pharmacol. Therap. 1994;17:426-433.
23 - Dou W, Jiao Y, Goorha S et coll. Nociception and the differential expression of cyclooxygenase-1 (COX-1), the COX-1 variant retaining intron-1 (COX-1v), and COX-2 in mouse dorsal root ganglia (DRG), Prostaglandins Other Lipid Mediat. 2004;74(1-4):29-43.
24 - Eisenach JC, Gebhart GF. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology. 1995;83(5):1046-1054.
25 - Endicott M. Principles of treatment for osteosarcoma. Clin. Tech. Small Anim. Pract. 2003;18(2):110-114.
26 - Fan TM, de Lorimier LP, Charney SC et coll. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement. J. Vet. Intern. Med. 2005;19(1):74-80.
27 - Garber K. Why it hurts: researchers seek mechanisms of cancer pain, J. Natl. Cancer Inst. 2003;95(11):770-772.
28 - Gogny M. Douleur et traitement de la douleur. Point Vét. 1993;24(149):27-32.
29 - Holland CT, Charles JA, Smith SH et coll. Hemihyperaesthesia and hyperresponsiveness resembling central pain syndrome in a dog with a forebrain oligodendroglioma. Aust. Vet. J. 2000;78(10):676-680.
30 - Housiaux N, Troncy E. L'analgésie transcutanée. Point Vét. 2002;33(224):50-53.
31 - Hugonnard M, Leblond A, Keroack S et coll. Attitudes and concerns of French veterinarians towards pain and analgesia in dogs and cats. Vet. Anaesth. Analg. 2004;31(3):154-163.
32 - Johnston IN, Milligan ED, Wieseler-Frank J. et coll. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci. 2004;24(33):9353-9365.
33 - Karai L, Brown DC, Mannes AJ et coll. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J. Clin. Invest. 2004;113(9):1344-1352.
34 - Keck G. Les anti-inflammatoires dans le traitement de la douleur. Point Vét. 1993;24(149):35-39.
35 - Keller SM, Carp NZ, Levy MN et coll. Chronic post thoracotomy pain, J. Cardiovasc. Surg. (Turin). 1994;35(6 Suppl 1):161-164.
36 - Keroack S, Langevin B, Troncy E. Analgésie chez le chien et chez le chat. Les analgésiques en phase périopératoire. Point Vét. 2002;33(224):20-25.
37 - Kotwal RS, O'Connor KC, Johnson TR et coll. A novel pain management strategy for combat casualty care. Ann. Emerg. Med. 2004;44(2):121-127.
38 - Kozela E, Pilc A, Popik P. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology (Berl). 2003;165(3):245-251.
39 - Lamont L. Management of chronic pain. In: Veterinary anesthesia and pain management secret. Hanley & Belfus Ed., Philadelphia, 2002:349-352.
40 - Lamont LA, Tranquilli WJ, Mathews KA. Adjunctive analgesic therapy. Vet. Clin. North Am. Small Anim. Pract. 2000;30(4):805-813.
41 - Maddison J, Page SW, Church D. Small animal clinical pharmacology. Saunders Ed. London. 2002:592p.
42 - Magni G. The use of antidepressants in the treatment of chronic pain. A review of the current evidence drugs. 1991;42(5):730-748.
43 - Magni G, Conlon P, Arsie D et coll. Tricyclic antidepressants in the treatment of cancer pain: a review. Pharmacopsychiatry. 1987;20(4):160-164.
44 - Maier C, Dertwinkel R, Mansourian N et coll. Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain-results of a randomized double-blinded, placebo-controlled trial. Pain. 2003;103(3):277-283.
45 - Michon P. Cyclo-oxygénase 3: des perspectives nouvelles pour d'anciennes molecules. Point Vét. 2005;36(252):10-11.
46 - Michon P, Dumas P. Intérêts des anti-inflammatoires non stéroïdiens dans la gestion du cancer. Point Vét. 2004;35(250):30-34.
47 - Milner RJ, Farese J, Henry CJ et coll. Bisphosphonates and cancer. J. Vet. Intern. Med. 2004;18(5):597-604.
48 - Nan KJ, Wei YC, Zhou FL et coll. Effects of depression on parameters of cell-mediated immunity in patients with digestive tract cancers. World J. Gastroenterol. 2004;10(2):268-272.
49 - Nickel JC, Downey J, Ardern D et coll. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J. Urol. 2004;172(2):551-554.
50 - Panerai AE, Bianchi M, Sacerdote P et coll. Antidepressants in cancer pain. J. Palliat. Care. 1991;7(4):42-44.
51 - Passik SD, Kirsh KL. Assessing aberrant drug-taking behaviors in the patient with chronic pain. Curr. Pain Headache Rep. 2004;8(4):289-294.
52 - Pinault L. Prescription des médicaments et délivrance au détail des médicaments vétérinaires. Prat. Méd. Chir. Anim. Comp. 2003;38:495-500.
53 - Pommerenke EW, Volm M. Reversal of doxorubicin-resistance in solid tumors by clomipramine. In Vivo. 1995;9(2):99-101.
54 - Pommier B, Beslot F, Simon A et coll. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system. J. Neurosci. 2002;22(5):2005-2011.
55 - Posadas EM, Dahut WL, Gulley J. The emerging role of bisphosphonates in prostate cancer. Am. J. Ther. 2004;11(1):60-73.
56 - Pouzot C, Nouvelles approches thérapeutiques dans la gestion de la douleur chronique arthrosique, cancéreuse et neurogène chez le chien. Thèse de médecine vétérinaire. ENV Lyon. 2003:166p.
57 - Quartaroli M, Fasdelli N, Bettelini L et col. GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice. Eur. J. Pharmacol. 2001;430(2-3):219-227.
58 - Quartaroli M, Carignani C, Dal Forno G et coll. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A, J. Pharmacol. Exp. Ther. 1999;290(1):158-169.
59 - Rabben T, Skjelbred P, Oye I. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J. Pharmacol. Exp. Ther. 1999;289(2):1060-1066.
60 - Riccardi A, Grasso D, Danova M. Bisphosphonates in oncology: physiopathologic bases and clinical activity. Tumori. 2003;89(3):223-236.
61 - Roques BP. Pharmacologie des différentes classes de récepteurs opioïdes cérébraux. Recueil de Médecine Vétérinaire. 1986;162(12):1321-1331.
62 - Roemer-Becuwe C, Vigano A, Romano F et coll. Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration J. Pain Symptom Manage. 2003;26(3):843-848.
63 - Sabino MA, Ghilardi JR, Jongen JL et coll. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res. 2002;62:7343-7349.
64 - Schwenkreis P, Maier C, Pleger B et coll. NMDA-mediated mechanisms in cortical excitability changes after limb amputation, Acta Neurol. Scand. 2003;108(3):179-184.
65 - Shannon M, Berde CB. Pharmacologic management of pain in children and adolescents. Pediatr. Clin. North Am. 1989;36(4):855-871.
66 - Steux R. Gestion de la douleur cancéreuse chez les carnivores domestiques. Thèse de médecine vétérinaire, ENV Toulouse. 2003:185p.
67 - Ta LE, Dionne RA. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen. Pain. 2004;111(1-2):13-21.
68 - Tranquilli W. Physiology of chronic pain, In: Veterinary anesthesia and pain management secret. Hanley & Belfus Ed. Philadelphia. 2002:345-347.
69 - Troncy E. Anesthésiologie du chien et du chat. Quelle analgésie pour les douleurs chroniques neurogènes ? Point Vét. 2002;33(223):9.
70 - Troncy E. Modalités d'approvisionnement et d'utilisation des antalgiques de palier III. Point Vét. 1999;30(203):677-679.
71 - Ueda H. Pain and QOL-morphine-tolerance and morphine-resistant neuropathic pain. Nippon Yakurigaku Zasshi. 2003;122(3):192-200. Article en japonais.
72 - Urch C. The pathophysiology of cancer-induced bone pain: current understanding. Palliat. Med. 2004;18(4):267-274.
73 - Vandaele E, Troncy E. Analgésie chirurgicale postopératoire. L'AINS s'injecte avant la chirurgie, mais n'est efficace qu'après. Point Vét. 2002;33(224):16-17.
74 - Varga A, Nugel H, Baehr R et coll. Reversal of multidrug resistance by amitriptyline in vitro. Anticancer Res. 1996;16(1):209-211.
75 - Ventafridda V, Ripamonti C, De Conno F et coll. Antidepressants increase bioavailability of morphine in cancer patients. Lancet. 1987;1(8543):1204.
76 - Wallace MS, Rowbotham MC, Katz NP et coll. A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology. 2002;59(11):1694-1700.
77 - Wiech K, Kiefer RT, Topfner S et coll. A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain. Anesth. Analg. 2004;98(2):408-413.
78 - Yamashiro K, Tomiyama N, Terada Y et coll. Neurons with spontaneous high-frequency discharges in the central nervous system and chronic pain. Acta Neurochir. Suppl. 2003;87:153-155.
79 - Zhu H, Brodsky M, Gorman AL et coll. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614. Brain Res. Mol. Brain Res. 2003;114(2):154-162.




En savoir plus

- Aas M, Moe L, Gamlem H et coll. Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP), Clin. Cancer Res. 1999;5(10 Suppl):3148s-3152s.
- Begon S, Pickering G, Eschalier A et coll. Magnesium increases morphine analgesic effect in different experimental models of pain. Anesthesiology. 2002;96(3):627-632.
- Crouail C. L'agressivité du chien âgé peut être liée à la douleur. La dépression d'involution est une autre cause possible. La Semaine Vétérinaire. 2003;(1105):12.
- Danoy N. Traitement médical de la douleur chez le chien. Thèse de Médecine Vétérinaire. ENV Toulouse. 1999:133p.
- Daut RL, Cleeland CS. The prevalence an severity of pain in cancer. Cancer. 1982;50:1913-1918.
- De Lorenzo MS, Yamaguchi K, Subbaramaiah K et coll. Bryostatin-1 stimulates the transcription of cyclooxygénase-2, Clin. Cancer Res. 2003;vol9:5036-5043.
- Foley KM. the treatment of cancer pain. N. Engl. J. Med. 1985;313:84-95.
- Haond C, Lambert L. Suivi, accompagnement et euthanasie, le suivi de l'animal âgé dans : Recommandations pratiques cliniques en gériatrie vétérinaire. Editions du Point Vét. 2004:255-262.
- Hirabayashi H, Fujisaki J. Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents. Clin. Pharmacokinet. 2003;42(15):1319-1330.
- Hoskin PJ. Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treat. Rev. 2003;29(4):321-327.
- Hudson JT, Slater MR, Taylor L et coll. Assessing repeatability and validity of a visual analogue scale questionnaire for use in assessing pain and lameness in dogs. Am. J. Vet. Res. 2004;65(12):1634-1643.
- Hugonnard M, Leblond A, Keroack S et coll. Evaluation et traitement de la douleur des carnivores domestiques, La douleur : résultats d'une enquête en clientèle. Point Vét. 2001;32(214):48-51.
- Kuduk SD, Ng C, Feng DM et coll. 2,3-diaminopyridine bradykinin B1 receptor antagonists. J. Med. Chem. 2004;47(26):6439-6442.
- Lamont LA, Tranquilli WJ, Grimm KA. Physiology of pain, Vet. Clin. North Am. Small Anim. Pract. 2000;30(4):703-728.
- Le Bars D. Les mécanismes physiologiques de contrôle de la douleur. Recueil de Médecine Vétérinaire. 1986;162(12):1297-1309.
- Lynch ME, Clark AJ. Comment on: Bell RF, Kalso K. Is intranasal ketamine an appropriate treatment for chronic non-cancer breakthrough pain? Pain. 2004;108:1-2. Pain. 2004;110(3):764.
- Makowski M, Grzela T, Niderla J et coll. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamictherapy in mice. Clin. Cancer Res. 2003;9:5417-5422.
- Max MB, Byas-Smith MG, Gracely RH et coll. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin. Neuropharmacol. 1995;18(4):360-368.
- Mason L, Moore RA, Edwards JE et coll. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord. 2004;5(1):28.
- Minotti V, De Angelis V, Righetti E et coll. Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain. Pain. 1998;74(2-3):133-137.
- Peter R, Mishra V, Fraser WD. Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ. 2004;328:335-336.
- Potter J, Higginson IJ. Pain experienced by lung cancer patients: a review of prevalence, causes and pathophysiology. Lung Cancer. 2004;43(3):247-257.
- Robin Y. Aspects symptomatologiques de la douleur. Recueil de Médecine Vétérinaire. 1986;162(12):1333-1337.
- Small EJ, Smith MR, Seaman JJ. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer. J. Clin. Oncol. 2003;21(23):4277-4284.
- Thamm DH, Mauldin EA, Edinger DT et coll. Primary osteosarcoma of the synovium in a dog. J. Am. Anim. Hosp. Assoc. 2000;36(4):326-331.
- Tramer MR, Glynn CJ. Magnesium Bier's block for treatment of chronic limb pain: a randomised, double-blind, cross-over study, Pain. 2002;99(1-2):235-241.
- Wiseman-Orr ML, Nolan AM, Reid J, et coll. Development of a questionnaire to measure the effects of chronic pain on health-related quality of life in dogs. Am. J. Vet. Res. 2004;65(8):1077-1084.
- Zhang H, Tian M, Li S et coll. Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients. Cancer Biother. Radiopharm. 2003;18(5):719-726.


En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...